Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surecell is an international medical group specializing in regenerative medicine and cellular therapies. The clinic primarily focuses on autologous treatments, which utilize the patient's own biological material to promote healing and tissue repair. Their core offerings include Platelet-Rich Plasma (PRP) and stem cell therapies, specifically targeting musculoskeletal conditions such as osteoarthritis, tendonitis, and ligament injuries. In addition to orthopedics, Surecell provides regenerative solutions for aesthetic concerns, including hair loss and skin rejuvenation. The company operates a network of clinics across Australia and Asia, emphasizing minimally invasive alternatives to traditional surgery. Surecell also engages in clinical research and education to advance the field of regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surecell Medical Clinic.